A Study to Assess the Pharmacokinetics and Safety of Single Doses of Anifrolumab in Healthy Subjects
Clinical trial NCT02601625 · COMPLETED
Trial details
- NCT number
- NCT02601625
- Sponsor
- AstraZeneca
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2015-11-16
- Primary completion
- 2016-05-25
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.